Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department

NCT00323219 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00323219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00323219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department
Lead sponsor
University of British Columbia
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
December 31, 2013
Enrollment
390 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cellulitis